These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 223531

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Acylovir in oral and ganglionic herpes simplex virus infections.
    Park NH, Pavan-Langston D, McLean SL.
    J Infect Dis; 1979 Nov; 140(5):802-6. PubMed ID: 316819
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Persistent reactivable latent herpes simplex virus infection in trigeminal ganglia of mice treated with antiviral drugs.
    Svennerholm B, Vahlne A, Lycke E.
    Arch Virol; 1981 Nov; 69(1):43-8. PubMed ID: 6271097
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evaluation of the antiherpetic activity of acyclovir in rabbits.
    Trousdale MD, Nesburn AB.
    Am J Med; 1982 Jul 20; 73(1A):155-60. PubMed ID: 6285707
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Studies on the effectiveness of levamisole on mice experimental herpetic keratitis. 1. Inhibition of trigeminal ganglionic latency of herpes simplex virus].
    Hiyama N.
    Nippon Ganka Gakkai Zasshi; 1983 Jul 20; 87(5):346-51. PubMed ID: 6310977
    [No Abstract] [Full Text] [Related]

  • 10. Study of HSV-1 DNA species from trigeminal ganglia of rabbits during acute and latent infections.
    Green MT, Qavi HB, SeGall GK.
    Curr Eye Res; 1987 Jan 20; 6(1):85-9. PubMed ID: 3030658
    [Abstract] [Full Text] [Related]

  • 11. Protective immunity against herpetic ocular disease in an outbred mouse model.
    Metcalf JF, Whitley RJ.
    Curr Eye Res; 1987 Jan 20; 6(1):167-71. PubMed ID: 3030641
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Acyclovir and vidarabine in the treatment of ulcerative herpes simplex keratitis.
    Pavan-Langston D, Lass J, Hettinger M, Udell I.
    Am J Ophthalmol; 1981 Dec 20; 92(6):829-35. PubMed ID: 7032303
    [Abstract] [Full Text] [Related]

  • 14. In vitro and in vivo resistance of herpes simplex virus to 9-(2-hydroxyethoxymethyl)guanine (acycloguanosine).
    Smith KO, Kennell WL, Poirier RH, Lynd FT.
    Antimicrob Agents Chemother; 1980 Feb 20; 17(2):144-50. PubMed ID: 6247967
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Ocular herpes simplex virus infections: reduced sensitivity to acyclovir in primary disease.
    Charles SJ, Gray JJ.
    Br J Ophthalmol; 1990 May 20; 74(5):286-8. PubMed ID: 2162190
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Acyclic antimetabolite therapy of experimental herpes simplex keratitis.
    Pavan-Langston D, Campbell R, Lass J.
    Am J Ophthalmol; 1978 Nov 20; 86(5):618-23. PubMed ID: 213976
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.